The cell lines HepG2.2.15 (clonal cells derived from human hepatoma cell line G2,) was provided by the 302 Military Hospital of China. Cultures were maintained as monolayers in DMEM (GIBCO) with nonessential amino acids, sodium pyruvate (90%) and 10% (v/v) heat inactivated fetal bovine serum at 37 °C in a humidified atmosphere with 5% CO 2 . The sterol derivatives under study were dissolved in ethanol and added at required concentrations to the cell culture. Cells incubated without the preparations served as the control.
Cytotoxicity Assay
The cytotoxicity of the compounds was evaluated on HepG2.2.15 cells by the standard MTS assay. In short, exponentially growing cells were seeded into 96-well plates at a density 1.0×10 5 cell/mL. The plates were incubated at 37 °C in a humidified 5% CO 2 atmosphere for 24 h. After the various concentrations of the test drugs being added into cultures treated 4d, the media was removed. MTS solution was added to all the wells, and incubation continued at 37 °C for 3 h. Untreated cells were used as control. The cell pathological changes were observed by microscope and then the absorbance was quantified at a wavelength of 490 nm with a BIORAD 550 spectrophotometer (CA, USA), Inhibition ratio (%) was calculated based on the equation (1):
(1)
Assays for HBsAg and HBeAg in the Cell Culture
HepG2.2.15 cells at a density 1.0×10 5 cells/mL were incubated in 96-well plates for the measurement of HBV antigens. After incubation with various concentrations of 1d-1f , 2d-2f or 3TC for 4 or 8 days, the culture medium was collected, cell debris was removed, and the supernatant was collected and performed at −20 °C. The levels of Hepatitis B surface antigen (HBsAg) and Hepatitis B e antigen (HBeAg) in culture supernatants of HepG2.2.15 cells were determined with an ELISA kit (DaAn Gene Corp. of Sun Yat-sen University, Guangzhou, China). The optical density (OD) was measured at a wavelength of 450 nm using a BIORAD 550 spectrophotometer. Inhibition ratio (%) was calculated based on the equation (1).
Acute Toxicity
Compound 1f was further investigated for its approximate LD 50 and 95% confidence interval in mice.
Kunming mice (Beijing Vital River Laboratory Animal Technology Company Limited, Beijing, China) of both sexes, weighing 18-22 g, were divided into six groups per six individuals matched in weight and size. The six groups were given intraperitoneal injection of compound 1f in dose of 56, 178, 350, 422, 750 and 1000 mg/kg respectively. The general behavior of the mice was observed continuously for 1, 4 and 24 h after the treatment.
The mice were further observed up to 14 days. Behavior, toxicity effects and mortality response were recorded. 
Synthesis

Materials and Methods
Reactions were monitored by TLC using silica gel coated aluminum sheets (Qingdao, China) and visualized in UV light (254 nm). 1 H-NMR and 13 C-NMR assays were recorded on a Bruker AVANCE 500 NMR spectrometer and chemical shifts are reported in form of δ (ppm). 2, 6-dimethyl-pyridine, CCl 4 , N-bromobutanimide (NBS) was served as the solvent (Beijing, China). HRMS spectra were performed on High-resolution ESI mass spectrum (Solarix 9.4T, Bruker, Germany). Melting points were measured at a rate of 5 °C/min using an X-5 micro melting point apparatus (Beijing, China). Cellular morphologies were observed using an inverted fluorescence microscope (Tokyo, Japan). Silica-gel column chromatography was performed using 200-300 mesh silica-gel. The yields were calculated based on the last step reaction. All solvents and chemicals used were analytical or high-performance liquid chromatography grade. Hz, =CH-)] was connected with δC 80.0 (C-8), which were similar with 1b. Besides, there were δC 83.4 (C-5) and
δC 80.0 (C-8) in the 13 C-NMR spectrum of compound 1f, which were very different from while δC 141.6 (C-5) and δC 138.6 (C-8) in the 13 C-NMR spectrum of 1b. It suggested that the peroxide bridge of compound 1f was synthesized according to all of the above analysis. And This inference can also be applied to compounds 1d and 1e.
General procedure for the derivatives (1a-1f, 2a-2f method as shown in Scheme 1)
Preparation of compound 1a and 2a:
Cholesterol (30.00 mmol) or β-sitosterol (30.00 mmol) was added to a solution of toluene (60.00 mmol) and acetic anhydride (60.00 mL) in pyridine (12.41 mmol).The mixture stirred with heating at reflux until the crude material was absence. After cooling the reaction mixture, the combined organic layer were washed with 0.1% hydrochlochric for two times, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography on silica gel to give desired products.
3β 122.7, 74.0, 56.7, 56.1, 50.0, 42.3, 39.7, 39.5, 38.1, 37.0, 36.6, 36.2, 35.8, 31.9, 31.8, 28.2, 28.0, 27.8, 24.3, 23.8, 22.8, 22.5, 21.4, 21.0, 19.3, 18.7, 11.9 7, 122.7, 74.0, 56.7, 56.7, 50.1, 42.4, 39.8, 38.2, 37.0, 36.6, 36.2, 36.2, 31.9, 31.9, 28.3, 28.2, 27.8, 24.3, 23.1, 21.4, 21.0, 19.3, 18.9, 16.2, 11.8 
Preparation of compound 1b and 2b:
Compound 1a or 2a (10.00 mmol) and NBS (10.00 mmol) was dissolved in dry tetrachloromethane (30.00 mmol). The mixture was refluxed at 85 °C for 4h with magnetic stirring, and illuminated by the meantime until the material 1a or 2a was absence. The crude product was redissolved with hot ethylacetate then was filtered, and then the filtrate was cooled overnight to obtained crude crystals, which was purified by recrystallization from ethylacetate to produce a light yellow solid. 6, 138.5, 120.2, 116.2, 72.8, 55.8, 55.4, 46.0, 42.9, 39.5, 39.1, 37.9, 37.1, 36.6, 36.2, 36.1, 28.1, 28.1, 28.1, 23.9, 23.0, 22.8, 22.6, 21.5, 21.0, 18.9, 16.2, 11.8 138.5, 120.2, 116.3, 72.8, 55.6, 54.5, 45.8, 42.9, 41.6, 41.0, 40.8, 39.1, 37.9, 37.1, 36.6, 36.5, 33.9, 28.1, 29.1, 26.1, 23.0, 21.0, 18.9, 19.7, 19.1, 17.1, 16.2, 12.0, 11.9. HRMS (ESI) m/z:477.37030 [M+Na] + . calcd. for C 31 H 50 O 2 454.38108.
Preparation of compound 1c and 2c:
Compound 1b or 2b was added (5.00 mmol) into ethanol (60.00 mL) and sodium hydroxide (12.50 mmol), then the mixture was heated to 80 °C with magnetic stirring until the end of the experiment. After extracting the solution with ethyl acetate, the organic layer was washed with distilled water to neutral. Then the organic layer was dried over anhydrous sodium sulfate and evaporating the solvent in vacuum pressure, the crude compound was obtained. Then the crude product was recrystallized from ethanol. 5, 139.8, 119.9, 116.3, 70.5, 55.9, 54.5, 46.3, 40.8, 39.5, 39.2, 38.4, 37.1, 36.2, 36.2, 36.2, 32.1, 28.1, 28.1, 23.9, 23.0, 22.8, 22.6, 21.2, 18.9, 16.3, 11.9. HRMS (ESI) 1H) , 5.37 (m, 1H, =CH-), 5.57 (m, 1H, =CH-), 0.62-2.50 (25H, methyl-and methylene-of steroid structure). 13 C-NMR (125 MHz, CDCl 3 , δ ppm): 141.5, 139.7, 119.6, 116.2, 70.5, 55.9, 54.5, 46.2, 42.9, 39.1, 38.4, 37.2, 37.0, 36.5, 33.9, 29.1, 28.7, 28.7, 26.5, 23.1, 23.0, 21.0, 21.1, 19.8, 19.0, 18.9, 16.3, 12.0, 11.8 
Preparation of compound 1d and 2d:
Product 1b or 2b (3.00 mmol) and Eosin Y (0.31 mmol) was added to anhydrous ethanol (100.00 mL). The air was bubbled into the liquid for approximately 2h by a micro air pump until the compound 1b or 2b was not detected. Then the solvent was evaporated under vacuum, chromatographed on the silica gel column and eluted with ethyl acetate/petroleum ether (10/1) to give compound 1d or 2d.
3β-O-Acetyl-5α,8α-cyclicobioxygen-6-vinyl-cholesterol (1d). White solid, m.p.: 137.5-138.2 °C. 1 H-NMR (500MHz, CDCl 3 , δ ppm): 0.79 (s, 3H, -CH 3 ), 0.85 (d, J = 2.5 Hz, 3H, -CH 3 ), 0.86 (d, J = 2.5 Hz, 3H, -CH 3 ), 0.88 (s, 3H, -CH 3 ), 2.01 (s, 3H, -CH 3 ), 2.11 (m, 2H), 4.97 (m, 1H), 6.23 (d, J = 8.5 Hz, 1H, =CH-), 6.49 (d, J = 8.5 Hz, 1H, =CH-), 0.57-2.38 (26H, methyl-and methylene-of steroid structure). 13 C-NMR (125 MHz, CDCl 3 , δ ppm): 170.1 (C=O), 135.4, 130.9, 81.7 69.5, 56.4, 51.5, 51.0, 44.7, 39.4, 39.4, 37.0, 35.9, 35.2, 34.3, 33.2, 28.2, 28.0, 26.2, 23.8, 23.4, 22.8, 22.5, 21.3, 20.6, 18.6, 18.1, 12.6 69.5, 56.3, 51.5, 51.0, 45.8, 44.7, 39.4, 37.0, 35.9, 34.3, 33.7, 33.2, 29.1, 28.2, 28.2, 26.2, 23.4, 23.0, 21.3, 20.6, 19.8, 19.0, 18.6, 18.1, 12.6, 12.0. HRMS (ESI) 
Preparation of compound 1e and 2e:
There are two routes to get compound 1e or 2e.
Route (1): Compound 1c or 2c (3.00 mmol) was dissolved in anhydrous ethyl alcohol (100.00 mL), and Eosin Y (0.31 mmol) was added. In this way, the yield of was 75.3%.
Route (2): Compound 1d or 2d (0.50 mmol), ethanol (30.00 mL) and 10% sodium hydroxide solution (2.50 mL) were added to a flask. The residue was chromatographed on silica gel column to give compound 1e or 2e, and the yield was 90.1%. 66.5, 56.4, 51.6, 51.1, 44.7, 39.4, 39.4, 37.0, 36.9, 36.0, 35.2, 34.7, 30.1, 28.2, 28.0, 23.8, 23.4, 22.8, 22.6, 20.6, 18.6, 18.2, 12.7 66.5, 56.3, 51.6, 51.0, 45.8, 44.7, 39.4, 37.0, 36.9， 35.6, 34.7, 33,7, 30.1, 29.1, 28.3, 26.0, 23.4, 23.0, 20.6, 19.8, 19.0, 18.6, 18.1, 12.6, 12. 
Preparation of compound 1f and 2f:
Compound 1e or 2e (1.50 mmol) was dissolved by acetone (50.00 mL), equipped with dropping funnel, surrounded by an ice-bath. The chromic acid solution (1.60 mmol) that had already been prepared was added into the mixture, and continued stirring 1h. Then the contents were poured into a breaker with chipped ice, the solid was separated by filtration. The residue was purified by silica gel column chromatograph and recrystallized from alcohol. 56.4, 51.4, 51.1,44.9, 43.6, 39.4, 39.4, 39.3, 37.3, 36.7, 35.9, 35.2, 28.3, 28.0, 23.8, 23.5, 22.8, 22.5, 20.5, 18.7, 17.5, 12.8 56.3, 51.5, 51.2, 45.8, 44.9, 43.7, 39.4, 37.4, 36.8, 35.6, 35.3, 33.7, 29.1, 28.3, 26.0, 23.5, 23.1, 20.6, 19.9 191, 18.7, 17.5, 12.8, 12. The optical rotation data of all six compounds were showed in Table 3 . The optical rotation were measured by AUTOPOLⅢ AUTOMATIC POLARIMETER (RUDOLPH RESEARCH ANALYTICAL). 
